Tissue Regeneration Suppliers For Served Medical Health Care Pharmaceuticals

Welcome to Gel4Med, the Smart Materials Company paving the way to the future of regenerative medicine. We are a team of like-minded and determined individuals, all sharing a vision for the betterment of patient outcomes. We believe that our ...

BIOLOT Medical is a company based on pain management, tissue regeneration, bone regeneration and wound healing. We aim to provide innovative medical solutions that make patients look younger, feel more active and remain active. It is our quality and ...

Kerecis is pioneering the use of fish skin and fatty acids in the globally expanding cellular-therapy and regenerative-medicine markets. The fatty-acid-rich products from the company’s patented technologies protect the body’s own tissues and enable ...

BRIM Biotechnology: bringing transformational treatments to patients sooner. BRIM Biotechnology applies integrated and efficient translational science to develop new treatments that help combat and cure disease. The company was founded in August ...

Alkahest is a clinical stage biopharmaceutical company targeting neurodegenerative and age-related diseases with transformative therapies derived from a deep understanding of the plasma proteome in aging and ...

Activen is a biotech company that has pioneered a new class of actives for the dermo-cosmetic industry. Activen scouts the genomic sequences of living organisms to find promising actives. Our research has helped us identify an untapped source of ...

3D Bio is a clinical-stage biotechnology company and leader in regenerative medicine using novel 3D-bioprinting and materials technologies to deliver safe, functional and personalized living tissues and organs, engineered on-demand for patients. ...

Juvena Therapeutics is a biotech company accelerating the development of regenerative therapeutics by unlocking the therapeutic potential of secreted proteins. Secreted proteins are a class of biologics with proven therapeutic potential that has ...

Ankasa is developing ART352-L as a novel regenerative medicine. Successful development of ART352-L will enhance the osteogenic properties of patient derived stem cells used in reconstructive surgeries and provide safe and effective enhancement of ...

AventaCell BioMedical Co., Ltd. ('AventaCell') is among the world leaders devoted to developing novel human-derived products for use in cell culture and tissue regeneration. Helios Bioscience is AventaCell's product family brand for their products ...

botiss biomaterials is an innovative, clinically and scientifically driven biotech company from Germany. Since the foundation of botiss biomaterials in 2009, we have become a leading developer, manufacturer and marketer of biomaterials for oral ...

A 100% Spanish owned biotechnological company specialising in the design, development and manufacture of nano-systems for drug delivery applications. Our technology is focussed on applications in the field of medicine where we develop systems to ...

Perseverance, passion and dedication are the engines that define our activity for over 25 years and, along with the values that we are committed to respect since the foundation of the company in 1995 – QUALITY, TEAM, DEVELOPMENT – have made us the ...

RoosterBio, Inc. is radically simplifying the use of adult human mesenchymal stem/stromal cells (hMSCs) to propel the commercialization of regenerative technologies. RoosterBio is enabling living cellular technologies to become more affordable, ...

CellProthera is a biotech company, incorporated in April 2008, and intended for the development, registration and marketing of innovative therapeutic solutions for the regeneration of organs damaged by disease or trauma from autologous blood ...

Origin is a privately-held, clinical-stage biotechnology company founded in June 2010 to develop and commercialize a novel, patented medical technology - delivering therapeutic molecules generated right at the point of care. Our technology is based ...

Capricor is Developing Transformative Cell and Exosome-based Therapeutics for the Treatment and Prevention of Diseases. Capricor Therapeutics, Inc. (Nasdaq: CAPR) is a clinical-stage biotechnology company focused on the discovery, development, and ...